Inhibitex, Inc. Email Format
Biotechnology ResearchGeorgia, United States11-50 Employees
Inhibitex, Inc. is a clinical-stage biotechnology company focused on developing therapies to treat or prevent serious infections. It aims to assemble a portfolio of high-value, differentiated infectious disease treatments with the potential to improve current standards of care. The company's pipeline targets major viral and bacterial infections, including herpes zoster, hepatitis C virus, and Staphylococcus aureus infections. Headquartered in Alpharetta, Georgia, the firm operates within the biotechnology research sector. With a small to mid-sized team, it concentrates on advancing clinical-stage programs that address infectious diseases from a medical and scientific perspective.